🇺🇸 SECHerbalife Nutrition Ltd.Qwen · 实盘不做把握 3/10不做原因:标的无直接敞口
北京时间·🕒 发布 18:50:36·⟳ 抓取 18:58:53 +8m17s·⚡ 决策 08-31 23:25:39 +4h26m·56.9 天前
Herbalife CEO Stephan Gratziani将于2026年10月31日卸任，CFO John DeSimone任临时CEO
CEO计划性卸任并转任顾问，有2个月过渡期、明确临时CEO（CFO John DeSimone）和正式继任流程。这不构成改变公司控制权、资本配置、客户信任或关键执行能力的强催化事件。经验规则明确指出'例行变动且经营机制成熟时通常不是交易事件'。自家案例库显示同一事件今日已有两条AVOID决策，方向一致。
📄 原文Herbalife Nutrition Ltd.↗ 原文
----- ea0303957-8k_herbalife.htm ----- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K…
不做 Herbalife Ltd.（HLF.US）
计划性CEO交接（转任顾问+临时CEO+继任流程），不改变控制权、资本配置或关键执行能力，不构成强催化。事件方向中性，无正期望交易机会。自家案例库今日已有同一事件两条AVOID决策。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Herbalife 8-K披露CEO Gratziani将于10月31日转任顾问，CFO DeSimone任临时CEO，董事会启动继任搜索。这是一次有过渡期、有临时继任者的计划性管理层交接，非突发免职或危机。按管理层治理经验框架，此类变动未改变控制权、资本配置或关键执行能力，不构成可交易催化。
🔎 新鲜度:最早出现 2026-08-31 · 扩散 low · price-in 风险 low ↗
反向证据
- 做空前查反向 · 来源 kb_search · 日期 2026-08-31 · 影响 none
8-K未披露任何负面原因；案例库记录显示为转任顾问+临时CEO+继任流程，属计划性交接而非被迫离任
检索:Herbalife CEO departure forced scandal negative reason
先例如何影响了这次决策
对本次决策的影响:事件本身不构成可交易催化，先例研究不影响AVOID结论
方向:无可用先例
涨幅量级:先例不足，无法校准幅度
工具执行结果 · 成功 4 · 降级 1 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 407 ms
{"result": "search_processed_events:agent query=`herbalife ceo stephan gratziani transition departure | herbalife leadership change 2026 | hlf 8-k item 5.02 ceo离任`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 72.0/72 小时、1234 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选，不能据此证明消息首发或不是重复；按当前事件继续正常研判。"} - fetch_decision_experience 成功 stock_tools HTTP · 196 ms
{ - stock_quote 降级 stock_tools HTTP · 1,614 ms
取价失败: Futu returned no quote - kb_search 成功 stock_tools HTTP · 2,644 ms
{ - search_case_library 成功 stock_tools HTTP · 505 ms
{"result": "search_case_library「HLF.US」—— 与这些标的相关的自家决策案例(本页 8 条,该标的全历史相关记录共 8 条；ENTER 只按该标的自己的腿统计):\n◆ HLF.US：相关历史决策 8 条 · 其中该标的 ENTER 0 条(0.0%) · 我们从没在这只票上 ENTER 过\n【对所查标的真 ENTER 过的:0 条 —— 相关案例里没有该标的自己的 ENTER 腿】\n【最近 8 条其它决策(多为「不做」,用来看这票最近在被什么消息刷屏)】\n• 2026-08-31 UTC 不做 · 事件:Herbalife Ltd.重申2026年三季
原文全文
展开原文 · 2,668 字
----- ea0303957-8k_herbalife.htm -----
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
August 25, 2026
Herbalife Ltd.
(Exact Name of Registrant as Specified in Charter)
Cayman Islands
1-32381
98-0377871
(State or Other Jurisdiction of
Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
P.O. Box 309
,
Ugland House
,
Grand Cayman
Cayman Islands
KY1-1104
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s telephone number, including
area code: c/o (
213
)
745-0500
Not Applicable
(Former Name or Former Address, if Changed Since
Last Report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Shares, par value $0.0005 per share
HLF
New York Stock Exchange
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02. Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 31, 2026, the Company announced that
Stephan Gratziani will transition from his role as Chief Executive Officer, effective October 31, 2026.
1
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Herbalife Ltd.
August 31, 2026
By:
/s/ HENRY C. WANG
Name:
Henry C. Wang
Title:
Chief Legal Officer and Corporate Secretary
2
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
August 25, 2026
Herbalife Ltd.
(Exact Name of Registrant as Specified in Charter)
Cayman Islands
1-32381
98-0377871
(State or Other Jurisdiction of
Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
P.O. Box 309
,
Ugland House
,
Grand Cayman
Cayman Islands
KY1-1104
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s telephone number, including
area code: c/o (
213
)
745-0500
Not Applicable
(Former Name or Former Address, if Changed Since
Last Report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Shares, par value $0.0005 per share
HLF
New York Stock Exchange
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02. Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 31, 2026, the Company announced that
Stephan Gratziani will transition from his role as Chief Executive Officer, effective October 31, 2026.
1
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Herbalife Ltd.
August 31, 2026
By:
/s/ HENRY C. WANG
Name:
Henry C. Wang
Title:
Chief Legal Officer and Corporate Secretary
2
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。